• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非同源末端连接增加使DNA依赖蛋白激酶成为葡萄膜黑色素瘤治疗干预的一个有前景的靶点。

Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.

作者信息

Doherty Rachel E, Bryant Helen E, Valluru Manoj K, Rennie Ian G, Sisley Karen

机构信息

Department of Oncology and Metabolism, The Medical School, Beech Hill Road, Sheffield, S10 2RX, UK.

Sheffield Ocular Oncology Service, Sheffield Teaching Hospitals, Royal Hallamshire Hospital, Glossop Road S10 2JF, UK.

出版信息

Cancers (Basel). 2019 Aug 30;11(9):1278. doi: 10.3390/cancers11091278.

DOI:10.3390/cancers11091278
PMID:31480356
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6769470/
Abstract

Uveal melanoma (UM) is the most common primary intraocular tumour in adults, with a mean survival of six months following metastasis. The survival rates have not improved in over 30 years. This study has shown that sister chromatid exchange (SCE) is low in UM which is likely due to a reduced expression of . As can function to suppress non-homologous end joining (NHEJ), this study therefore investigated NHEJ in UM. The activation of the catalytic subunit of the NHEJ pathway protein DNA-dependent protein kinase (DNA-PK) was measured by analysing the foci formation and the ligation efficiency by NHEJ determined using a plasmid-based end-joining assay. Using small-interfering RNA (siRNA) knock-down, and chemical inhibitors of DNA-PK, the survival of primary UM cultures and two cell lines were determined. To assess the homologous recombination capacity in response to the inhibition of DNA-PK, a SCE analysis was performed. In addition, to support the findings, the messenger RNA (mRNA) expression of genes associated with NHEJ was analysed using the Cancer Genome Atlas (TCGA)-UM RNAseq data ( = 79). The NHEJ activity and DNA-PKcs activation was upregulated in UM and the inhibition of DNA-PK selectively induced apoptosis and sensitized to ionising radiation and inter-strand cross-linking agents. The inhibition of the NHEJ protein DNA-PK is lethal to UM, indicating a potentially effective therapeutic option, either alone or as a sensitizer for other treatments.

摘要

葡萄膜黑色素瘤(UM)是成人中最常见的原发性眼内肿瘤,转移后平均生存期为6个月。30多年来生存率一直没有提高。本研究表明,UM中的姐妹染色单体交换(SCE)较低,这可能是由于……表达降低所致。由于……可抑制非同源末端连接(NHEJ),因此本研究对UM中的NHEJ进行了调查。通过分析灶形成以及使用基于质粒的末端连接测定法测定的NHEJ连接效率,来测量NHEJ途径蛋白DNA依赖性蛋白激酶(DNA-PK)催化亚基的激活情况。使用小干扰RNA(siRNA)敲低和DNA-PK的化学抑制剂,测定原发性UM培养物和两种细胞系的存活率。为了评估对DNA-PK抑制的同源重组能力,进行了SCE分析。此外,为了支持这些发现,使用癌症基因组图谱(TCGA)-UM RNAseq数据(n = 79)分析了与NHEJ相关基因的信使RNA(mRNA)表达。UM中的NHEJ活性和DNA-PKcs激活上调,抑制DNA-PK可选择性诱导细胞凋亡,并使其对电离辐射和链间交联剂敏感。抑制NHEJ蛋白DNA-PK对UM具有致死性,表明这是一种潜在有效的治疗选择,可单独使用或作为其他治疗的增敏剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/4c57775cdbca/cancers-11-01278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/bae0c27777a7/cancers-11-01278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/38858cd626e4/cancers-11-01278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/a66f3df429b8/cancers-11-01278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/4c57775cdbca/cancers-11-01278-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/bae0c27777a7/cancers-11-01278-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/38858cd626e4/cancers-11-01278-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/a66f3df429b8/cancers-11-01278-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53d9/6769470/4c57775cdbca/cancers-11-01278-g004.jpg

相似文献

1
Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.非同源末端连接增加使DNA依赖蛋白激酶成为葡萄膜黑色素瘤治疗干预的一个有前景的靶点。
Cancers (Basel). 2019 Aug 30;11(9):1278. doi: 10.3390/cancers11091278.
2
Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia.FANCD2 减少会影响葡萄膜黑素瘤和范可尼贫血中自发的 SCE 和 RAD51 焦点形成。
Oncogene. 2013 Nov 14;32(46):5338-46. doi: 10.1038/onc.2012.627. Epub 2013 Jan 14.
3
Inhibition of DNA-PKcs activity re-sensitizes uveal melanoma cells to radio- and chemotherapy.抑制 DNA-PKcs 活性可使葡萄膜黑素瘤细胞对放化疗重新敏感。
Biochem Biophys Res Commun. 2020 Feb 12;522(3):639-646. doi: 10.1016/j.bbrc.2019.11.133. Epub 2019 Nov 28.
4
Inhibition of homologous recombination by variants of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs).DNA依赖性蛋白激酶(DNA-PKcs)催化亚基变体对同源重组的抑制作用。
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1345-50. doi: 10.1073/pnas.0406466102. Epub 2005 Jan 24.
5
Biochemical evidence for Ku-independent backup pathways of NHEJ.非同源末端连接(NHEJ)的不依赖Ku的备用途径的生化证据。
Nucleic Acids Res. 2003 Sep 15;31(18):5377-88. doi: 10.1093/nar/gkg728.
6
DNA-PK inhibition causes a low level of H2AX phosphorylation and homologous recombination repair in Medaka (Oryzias latipes) cells.DNA-PK 抑制导致鱼类(Oryzias latipes)细胞中 H2AX 磷酸化和同源重组修复水平降低。
Biochem Biophys Res Commun. 2012 Dec 14;429(3-4):131-6. doi: 10.1016/j.bbrc.2012.10.128. Epub 2012 Nov 7.
7
Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.非同源末端连接是哺乳动物细胞中修复氟达拉滨诱导的DNA双链断裂的相关途径。
Mutat Res. 2008 Nov 10;646(1-2):8-16. doi: 10.1016/j.mrfmmm.2008.08.013. Epub 2008 Sep 4.
8
Brca2/Xrcc2 dependent HR, but not NHEJ, is required for protection against O(6)-methylguanine triggered apoptosis, DSBs and chromosomal aberrations by a process leading to SCEs.Brca2/Xrcc2依赖的同源重组修复(HR)而非非同源末端连接(NHEJ),对于通过导致姐妹染色单体交换(SCE)的过程来保护细胞免受O(6)-甲基鸟嘌呤引发的凋亡、双链断裂(DSB)和染色体畸变是必需的。
DNA Repair (Amst). 2009 Jan 1;8(1):72-86. doi: 10.1016/j.dnarep.2008.09.003. Epub 2008 Oct 21.
9
Human polynucleotide kinase participates in repair of DNA double-strand breaks by nonhomologous end joining but not homologous recombination.人类多核苷酸激酶通过非同源末端连接参与DNA双链断裂的修复,但不参与同源重组。
Cancer Res. 2007 Jul 15;67(14):6619-25. doi: 10.1158/0008-5472.CAN-07-0480.
10
Mechanisms of DNA double strand break repair and chromosome aberration formation.DNA双链断裂修复及染色体畸变形成的机制。
Cytogenet Genome Res. 2004;104(1-4):14-20. doi: 10.1159/000077461.

引用本文的文献

1
Co-Targeting of DTYMK and PARP1 as a Potential Therapeutic Approach in Uveal Melanoma.靶向 DTYMK 和 PARP1 联合治疗葡萄膜黑色素瘤的潜在治疗方法。
Cells. 2024 Aug 14;13(16):1348. doi: 10.3390/cells13161348.
2
Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment.通过胚胎干细胞微环境调节葡萄膜黑色素瘤中的DNA损伤反应。
BMC Cancer. 2024 Apr 24;24(1):519. doi: 10.1186/s12885-024-12290-x.
3
DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy and .

本文引用的文献

1
Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma.预后良好与不良的葡萄膜黑色素瘤中DNA修复基因的差异表达
Cancers (Basel). 2019 Aug 2;11(8):1104. doi: 10.3390/cancers11081104.
2
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma.聚(ADP-核糖)聚合酶(PARP)抑制增强葡萄膜黑色素瘤对化疗的反应。
Cancers (Basel). 2019 May 29;11(6):751. doi: 10.3390/cancers11060751.
3
How to MEK the best of uveal melanoma: A systematic review on the efficacy and safety of MEK inhibitors in metastatic or unresectable uveal melanoma.
DNA-PKcs 抑制剂使神经内分泌肿瘤细胞对肽受体放射性核素治疗敏感 。
Theranostics. 2023 May 21;13(10):3117-3130. doi: 10.7150/thno.82963. eCollection 2023.
4
Novel Treatments of Uveal Melanoma Identified with a Synthetic Lethal CRISPR/Cas9 Screen.通过合成致死性CRISPR/Cas9筛选鉴定出的葡萄膜黑色素瘤新疗法
Cancers (Basel). 2022 Jun 29;14(13):3186. doi: 10.3390/cancers14133186.
5
Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models.第三代溶瘤单纯疱疹病毒在难治性软组织肉瘤异种移植模型中的疗效
Mol Ther Oncolytics. 2022 Apr 26;25:225-235. doi: 10.1016/j.omto.2022.04.010. eCollection 2022 Jun 16.
6
Gut Microbiota Dysbiosis Accelerates Prostate Cancer Progression Through Increased LPCAT1 Expression and Enhanced DNA Repair Pathways.肠道微生物群失调通过增加LPCAT1表达和增强DNA修复途径加速前列腺癌进展。
Front Oncol. 2021 Jun 17;11:679712. doi: 10.3389/fonc.2021.679712. eCollection 2021.
7
Spliceosome Mutations in Uveal Melanoma.葡萄膜黑素瘤中的剪接体突变。
Int J Mol Sci. 2020 Dec 15;21(24):9546. doi: 10.3390/ijms21249546.
8
Inhibition of ATM Increases the Radiosensitivity of Uveal Melanoma Cells to Photons and Protons.抑制 ATM 可增加葡萄膜黑色素瘤细胞对光子和质子的放射敏感性。
Cancers (Basel). 2020 May 28;12(6):1388. doi: 10.3390/cancers12061388.
9
Uveal Melanoma.葡萄膜黑色素瘤
Cancers (Basel). 2019 Dec 10;11(12):1986. doi: 10.3390/cancers11121986.
如何最大限度地发挥脉络膜黑色素瘤的疗效:MEK 抑制剂在转移性或不可切除脉络膜黑色素瘤中的疗效和安全性的系统评价。
Eur J Cancer. 2018 Nov;103:41-51. doi: 10.1016/j.ejca.2018.08.005. Epub 2018 Sep 8.
4
Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).葡萄膜黑色素瘤:发病率、治疗及生存情况的5年更新(监测、流行病学和最终结果计划,1973 - 2013年)
Ocul Oncol Pathol. 2018 Apr;4(3):145-151. doi: 10.1159/000480640. Epub 2017 Oct 13.
5
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics.TCGA 泛癌临床数据资源整合,推动高质量生存预后分析。
Cell. 2018 Apr 5;173(2):400-416.e11. doi: 10.1016/j.cell.2018.02.052.
6
How cells ensure correct repair of DNA double-strand breaks.细胞如何确保正确修复 DNA 双链断裂。
J Biol Chem. 2018 Jul 6;293(27):10502-10511. doi: 10.1074/jbc.TM118.000371. Epub 2018 Feb 5.
7
Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.美法仑经皮肝灌注治疗葡萄膜黑色素瘤:一种针对罕见病的安全有效的治疗方式。
J Surg Oncol. 2018 May;117(6):1170-1178. doi: 10.1002/jso.24956. Epub 2017 Dec 28.
8
Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas.大脉络膜黑色素瘤患者质子束照射后的长期预后
JAMA Ophthalmol. 2017 Nov 1;135(11):1191-1196. doi: 10.1001/jamaophthalmol.2017.3805.
9
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.综合分析确定了葡萄膜黑色素瘤的四个分子和临床亚组。
Cancer Cell. 2017 Aug 14;32(2):204-220.e15. doi: 10.1016/j.ccell.2017.07.003.
10
GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi.脉络膜痣中的GNAQ和GNA11突变及下游YAP激活
Br J Cancer. 2017 Sep 5;117(6):884-887. doi: 10.1038/bjc.2017.259. Epub 2017 Aug 15.